mVISE delivers solid FY25 prelims with rising EBITDA despite a sharper-than-expected sales decline. Recurring revenues and margins improved, while the scalable platform leaves upside from future M&A.
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
mVISE delivers solid FY25 prelims with rising EBITDA despite a sharper-than-expected sales decline. Recurring revenues and margins improved, while the scalable platform leaves upside from future M&A.
